Hana Pharm Income Statement

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2017	FY 2016
Period Ending	Dec '17 Dec 31, 2017	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
Operating Revenue	139,331	139,331	124,535
Other Revenue	-0	-0	-
Revenue	139,331	139,331	124,535
Revenue Growth (YoY)	-	11.88%	-
Cost of Revenue	45,328	45,328	40,859
Gross Profit	94,003	94,003	83,676
Selling, General & Admin	59,248	59,248	55,580
Research & Development	2,214	2,214	3,424
Other Operating Expenses	137.99	137.99	143.58
Operating Expenses	62,192	62,192	60,006
Operating Income	31,811	31,811	23,671
Interest Expense	-1,044	-1,044	-1,481
Interest & Investment Income	89.51	89.51	81.14
Currency Exchange Gain (Loss)	75.51	75.51	-25.86
Other Non Operating Income (Expenses)	-205.42	-205.42	-166.64
EBT Excluding Unusual Items	30,727	30,727	22,078
Gain (Loss) on Sale of Assets	234.01	234.01	-19.1
Asset Writedown	-	-	-108.48
Pretax Income	30,961	30,961	21,950
Income Tax Expense	6,658	6,658	4,520
Earnings From Continuing Operations	24,302	24,302	17,431
Minority Interest in Earnings	2.15	2.15	-
Net Income	24,305	24,305	17,431
Net Income to Common	24,305	24,305	17,431
Net Income Growth	-	39.43%	-
Shares Outstanding (Basic)	11	11	8
Shares Outstanding (Diluted)	11	11	8
Shares Change (YoY)	-	39.75%	-
EPS (Basic)	2243.00	2243.00	2248.00
EPS (Diluted)	2243.00	2243.00	2248.00
EPS Growth	-	-0.22%	-
Free Cash Flow	15,187	15,187	4,154
Free Cash Flow Per Share	1401.56	1401.56	535.67
Gross Margin	67.47%	67.47%	67.19%
Operating Margin	22.83%	22.83%	19.01%
Profit Margin	17.44%	17.44%	14.00%
Free Cash Flow Margin	10.90%	10.90%	3.34%
EBITDA	35,333	35,333	27,349
EBITDA Margin	25.36%	25.36%	21.96%
D&A For EBITDA	3,522	3,522	3,678
EBIT	31,811	31,811	23,671
EBIT Margin	22.83%	22.83%	19.01%
Effective Tax Rate	21.51%	21.51%	20.59%
Advertising Expenses	1,858	1,858	1,736

Source: S&P Capital IQ. Standard template. Financial Sources.